XML 35 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Changes in Common Stock Options

The following summarizes the changes in common stock options for the nine months ended September 30, 2025:

 




 

 

Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining Contractual Term (Years)

 

 

Aggregate Intrinsic Value (In thousands)

 

Outstanding as of December 31, 2024

 

 

2,231,600

 

 

$

1.77

 

 

 

6.0

 

 

$

971

 

Granted

 

 

70,000

 

 

$

2.11

 

 

 

 

 

 

 

Exercised

 

 

(14,000

)

 

$

1.88

 

 

 

 

 

 

 

Forfeited

 

 

(83,500

)

 

$

2.95

 

 

 

 

 

 

 

Outstanding as of September 30, 2025

 

 

2,204,100

 

 

$

1.74

 

 

 

5.3

 

 

$

761

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options exercisable as of September 30, 2025

 

 

1,791,600

 

 

$

1.59

 

 

 

4.6

 

 

$

754

 

Disclosure Of Share Based Compensation Arrangements By Share Based Payment Award

The following summarizes the restricted stock awards and related stock-based compensation expense (in thousands, except share count and award fair value):

 

 

Grant Date

Vesting Date

Restricted Stock Granted

 

Per Share Grant Date Fair Value

 

Compensation Expense for the nine months ended September 30,

 

Unrecognized Compensation Expense as of,

 

 

 

 

 

 

 

 

 

2024

 

2025

 

September 30, 2025

 

Employees

 

March 1, 2023

March 1, 2024

 

97,290

 

$

2.53

 

 

 

 

 

 

 

Non-executive directors

 

March 31, 2023

March 31, 2024

 

90,000

 

$

2.87

 

 

43

 

 

 

 

 

Employees

 

March 7, 2024

March 7, 2025

 

128,044

 

$

2.93

 

 

213

 

 

67

 

 

 

Non-executive directors

 

March 7, 2024

March 7, 2025

 

75,000

 

$

2.93

 

 

125

 

 

40

 

 

 

Employees

 

January 1, 2025

December 31, 2028 [1]

 

125,000

 

$

1.85

 

 

 

 

43

 

 

188

 

Employees

 

March 6, 2025

March 6, 2026

 

68,051

 

$

2.11

 

 

 

 

82

 

 

62

 

Non-executive directors

 

March 6, 2025

March 6, 2026 [2]

 

100,000

 

$

2.11

 

 

 

 

120

 

 

91

 

Total

 

 

 

 

 

 

 

$

381

 

$

352

 

$

341

 

[1] These restricted stock awards vest 25% annually over four years, until fully vested on December 31, 2028.

[2] These restricted stock awards vest 25% quarterly over one year, until fully vested on March 6, 2026.